{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:51:41Z","timestamp":1785520301698,"version":"3.56.0"},"reference-count":29,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":697,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1002\/jcph.182","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T02:16:52Z","timestamp":1381544212000},"page":"1294-1302","source":"Crossref","is-referenced-by-count":11,"title":["Early-stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients"],"prefix":"10.1002","volume":"53","author":[{"given":"Hong","family":"Sun","sequence":"first","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"MacLeod","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Mostoller","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mahon","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Han","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Renger","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshui","family":"Ma","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Brown","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Schulz","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary G.","family":"Kay","sequence":"additional","affiliation":[{"name":"Cognitive Research Corporation; St. Petersburg FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Joseph","family":"Herring","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lines","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gail","family":"Murphy","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"10.1002\/jcph.182-BIB0001|jcph182-cit-0001","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/mol.59.3.415","article-title":"Genomics meets histamine receptors: new subtypes, new receptors","volume":"59","author":"Hough","year":"2001","journal-title":"Mol Pharmacol."},{"key":"10.1002\/jcph.182-BIB0002|jcph182-cit-0002","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev.pa.17.040177.001545","article-title":"Histaminergic mechanisms in brain","volume":"17","author":"Schwartz","year":"1977","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"10.1002\/jcph.182-BIB0003|jcph182-cit-0003","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/156802608784936728","article-title":"Histamine H3 antagonists as wake-promoting and pro-cognitive agents","volume":"8","author":"Stocking","year":"2008","journal-title":"Curr Top Med Chem."},{"key":"10.1002\/jcph.182-BIB0004|jcph182-cit-0004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.drudis.2009.02.011","article-title":"The histamine H3 receptor as a therapeutic drug target for CNS disorders","volume":"14","author":"Gemkow","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1002\/jcph.182-BIB0005|jcph182-cit-0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.110.166876","article-title":"Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease","volume":"336","author":"Brioni","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1002\/jcph.182-BIB0006|jcph182-cit-0006","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br J Pharmacol."},{"key":"10.1002\/jcph.182-BIB0007|jcph182-cit-0007","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/clpt.2010.205","article-title":"Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers","volume":"88","author":"Iannone","year":"2010","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.182-BIB0008|jcph182-cit-0008","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00213-010-2158-3","article-title":"Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers","volume":"215","author":"James","year":"2011","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1002\/jcph.182-BIB0009|jcph182-cit-0009","first-page":"A272","article-title":"The histamine inverse agonist ML-0249 in obstructive sleep apnea patients on CPAP with excessive daytime sleepiness: a randomized, controlled, adaptive crossover study","volume":"33","author":"Herring","year":"2010","journal-title":"Sleep"},{"key":"10.1002\/jcph.182-BIB0010|jcph182-cit-0010","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/jcph.182-BIB0011|jcph182-cit-0011","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/clpt.2010.302","article-title":"Comparative effectiveness: the fourth hurdle in drug development and a role for clinical pharmacology","volume":"89","author":"Honig","year":"2011","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.182-BIB0012|jcph182-cit-0012","volume-title":"International classification of sleep disorders: diagnostic and coding manual","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1002\/jcph.182-BIB0013|jcph182-cit-0013","first-page":"218","volume-title":"Clinical global impressions new clinical drug evaluation unit (ECDEU) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/jcph.182-BIB0014|jcph182-cit-0014","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1002\/jcph.182-BIB0015|jcph182-cit-0015","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0013-4694(82)90142-0","article-title":"Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence","volume":"53","author":"Mitler","year":"1982","journal-title":"Electroencephalogr Clin Neurophysiol."},{"key":"10.1002\/jcph.182-BIB0016|jcph182-cit-0016","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1378\/chest.101.4.893","article-title":"Maintenance of wakefulness test in obstructive sleep apnea syndrome","volume":"101","author":"Poceta","year":"1992","journal-title":"Chest"},{"key":"10.1002\/jcph.182-BIB0017|jcph182-cit-0017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.brainresbull.2003.12.015","article-title":"A driving simulation task: correlations with Multiple Sleep Latency Test","volume":"63","author":"Pizza","year":"2004","journal-title":"Brain Res Bull."},{"key":"10.1002\/jcph.182-BIB0018|jcph182-cit-0018","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1744-859X-6-4","article-title":"A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study","volume":"6","author":"Biederman","year":"2007","journal-title":"Ann Gen Psychiatry"},{"key":"10.1002\/jcph.182-BIB0019|jcph182-cit-0019","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hup.983","article-title":"Effects of modafinil on simulator driving and self-assessment of driving following sleep deprivation","volume":"23","author":"Gurtman","year":"2008","journal-title":"Hum Psychopharmacol."},{"key":"10.1002\/jcph.182-BIB0020|jcph182-cit-0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.aap.2007.08.014","article-title":"Daytime driving simulation performance and sleepiness in obstructive sleep apnoea patients","volume":"40","author":"Pizza","year":"2008","journal-title":"Accid Anal Prev."},{"key":"10.1002\/jcph.182-BIB0021|jcph182-cit-0021","first-page":"39","volume-title":"Sleep deprivation: clinical issues, pharmacology and sleep loss effects","author":"Dorrian","year":"2005"},{"key":"10.1002\/jcph.182-BIB0022|jcph182-cit-0022","volume-title":"WAIS-R manual","author":"Wechsler","year":"1981"},{"key":"10.1002\/jcph.182-BIB0023|jcph182-cit-0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/sleep\/28.1.123","article-title":"The clinical use of the MSLT and MWT","volume":"28","author":"Arand","year":"2005","journal-title":"Sleep"},{"key":"10.1002\/jcph.182-BIB0024|jcph182-cit-0024","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/sleep\/28.1.113","article-title":"Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of Wakefulness test","volume":"28","author":"Littner","year":"2005","journal-title":"Sleep."},{"key":"10.1002\/jcph.182-BIB0025|jcph182-cit-0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.wnp.0000190415.83841.17","article-title":"ACNS clinical controversy: MSLT and MWT have limited clinical utility","volume":"23","author":"Bonnet","year":"2006","journal-title":"J Clin Neurophysiol."},{"key":"10.1002\/jcph.182-BIB0026|jcph182-cit-0026","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1378\/chest.08-0822","article-title":"Multiple sleep latency test and maintenance of wakefulness test","volume":"134","author":"Sullivan","year":"2008","journal-title":"Chest."},{"key":"10.1002\/jcph.182-BIB0027|jcph182-cit-0027","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.2009.1987","article-title":"Funding of US biomedical research, 2003-2008","volume":"303","author":"Dorsey","year":"2010","journal-title":"JAMA."},{"key":"10.1002\/jcph.182-BIB0028|jcph182-cit-0028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov."},{"key":"10.1002\/jcph.182-BIB0029|jcph182-cit-0029","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.182","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.182\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:02:49Z","timestamp":1657803769000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.182"}},"subtitle":["The Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.182","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}